Lambutrix (Lorazepam)

Lambutrix (lorazepam) acts on the central nervous system to alleviate conditions mediated by excessive neuronal excitation.

• Anxiety disorders: reduction of excessive anxiety and associated physiological symptoms.
• Insomnia associated with anxiety: facilitation of sleep onset and maintenance.
• Preoperative sedation: provision of calmness and amnesia before surgical procedures.
• Status epilepticus: rapid control of prolonged seizure activity when other measures are insufficient.

• Lorazepam enhances GABAergic neurotransmission by binding to the benzodiazepine site on GABA‑A receptors. This increases the frequency of chloride channel opening, leading to greater chloride influx, neuronal hyperpolarization, and reduced excitability throughout the central nervous system.

Lambutrix may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dizziness: sensation of light‑headedness or imbalance.
• Headache: mild to moderate cranial pain.
• Muscle weakness: reduced muscular strength or coordination.
• Nausea: feeling of queasiness or urge to vomit.
• Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing requiring medical attention.
• Severe hypotension: marked drop in blood pressure leading to faintness.
• Paradoxical reactions: agitation, aggression, or hallucinations.
• Dependence or withdrawal: signs of physical or psychological dependence with abrupt discontinuation.
• Anaphylaxis: rare severe allergic reaction with rash, swelling, or airway compromise.
• Hepatic dysfunction: abnormal liver enzyme elevations.

Lambutrix should be used with caution in specific clinical situations.

• Pregnancy: Category D – potential risk to the fetus; avoid unless clearly needed.
• Elderly patients: increased sensitivity; start with lower doses and monitor closely.
• Renal or hepatic impairment: dose adjustment may be required due to altered clearance.
• Concomitant CNS depressants: risk of additive sedation and respiratory depression.
• History of substance abuse: higher potential for dependence; consider alternative therapy.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lambutrix can interact with several drug classes, influencing its safety profile.

Major Interactions (Avoid)

• Opioids: synergistic respiratory depression and profound sedation.
• Barbiturates: enhanced CNS depression and risk of coma.
• Alcohol: additive sedative effects and impaired psychomotor function.
• Antifungals (e.g., ketoconazole): increased lorazepam plasma concentrations.
• Macrolide antibiotics (e.g., erythromycin): elevated lorazepam levels.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs, SNRIs): possible increased sedation.
• Antihistamines: additive drowsiness.
• Anticonvulsants (phenytoin, carbamazepine): may reduce lorazepam efficacy.
• Cimetidine: modest increase in lorazepam exposure.
• Herbal supplements (St. John’s wort): potential reduction in therapeutic effect.